Visterra Raises $6 Million, Launches Singapore Arm
Published: Jul 12, 2010
Mass High Tech -- Cambridge biotech startup Visterra Inc., formerly known as Parasol Therapeutics, has landed $6 million in its first round of funding, backed by Flagship Ventures, Lux Capital and Polaris Venture Partners. The news accompanies an announcement of the launch of Visterra Singapore Pte. Ltd. from Visterra, the Singapore-MIT Alliance for Research and Technology (SMART) Center and the National Research Foundation of Singapore.